Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base ...
End-to-end pipelines and regulatory advances aim to expand gene editing to broad patient populations Ajay Gannerkote, ...
The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a ...
Eli Lilly has entered a research collaboration worth up to $2.25 billion with AI biotech Profluent to develop custom enzymes for advanced genetic medicines. The deal gives Lilly exclusive rights to ...
A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes ...
Gene editing, a set of techniques used to alter sections of an organism's DNA, is helping scientists cure diseases previously considered untreatable. That's why biotechs that specialize in gene ...
Key Points Interested in Beam Therapeutics Inc.? Here are five stocks we like better. Beam Therapeutics said its sickle cell ...
METiS TechBio (7666.HK), a global leader in AI-powered drug delivery innovation, today announced that new preclinical data ...
UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene into human airway cells, restoring key biological function in a laboratory ...
In a world first, a research team at the University of Zurich has successfully treated mice carrying an inherited form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results